月旦知識庫
 
  1. 熱門:
 
首頁 臺灣期刊   法律   公行政治   醫事相關   財經   社會學   教育   其他 大陸期刊   核心   重要期刊 DOI文章
中醫藥雜誌 本站僅提供期刊文獻檢索。
  【月旦知識庫】是否收錄該篇全文,敬請【登入】查詢為準。
最新【購點活動】


篇名
黃耆皂Ⅳ(astragaloside Ⅳ)對人類大腸癌細胞株(HT-29)細胞增殖和基質金屬蛋白(Matrix Metalloproteinase)基因表現的影響
並列篇名
THE EFFECTS OF ASTRAGALOSIDE Ⅳ ON THE CELL PROLIFERATION AND MATRIX METALLOPROTEINASE MESSENGER RNA EXPRESSION OF THE HUMAN COLON CANCER CELL LINE (HT-29)
作者 陳光偉蘇進成林昭庚
中文摘要
惡性腫瘤是國人十大死亡原因的首位,大腸癌躍居癌症死亡的第三位。有文獻報導大腸癌的復發或轉移和基質金屬蛋白{^FAF0^} MMP-2 、MMP-7 和MMP-9 的過度表達有正相關。黃耆皂{^FAF5^}Ⅳ (astragaloside Ⅳ )是黃耆之主要成分。本研究結果發現黃耆皂{^FAF5^}Ⅳ 在濃度10~100 ng/mL 作用12~48 小時皆可促進人類大腸癌HT-29 細胞株的生長,尤其在50 ng/mL 時更明顯。研究結果亦發現MMP-2 mRNA 在黃耆皂{^FAF5^}Ⅳ 濃度10 及20 ng/mL 時有明顯表達,但在濃度50~100ng/mL 時則有抑制的作用。黃耆皂{^FAF5^}Ⅳ 在濃度20~100 ng/mL 時TIMP-1 mRNA 有明顯表達,而MMP-7 、MMP-9 及TIMP-2 皆沒有表達。Malignant tumor (cancer) is the most important disease of the top ten causes of death in Taiwan. Among cancer types, colon cancer is the third most common cause of cancer-related mortality. The metastases and recurrent rate of colon cancer was correlated with the mRNA level of Matrix Metalloproteinase (MMP). AstragalosideⅣ is one of the important constituents of Huang-qi. In the present study, our results showed that the cell proliferation rate of HT-29 was stimulated by treatment with Astragaloside Ⅳ at 10-100 ng/mL for 12-48 hrs, especially high at 50 ng/mL. The mRNA level of MMP-2 was elevated by Astragaloside Ⅳ at 10 and 20 ng/mL. However, this level was decreased by Astragaloside Ⅳ at 50 and 100 ng/mL. The mRNA level of TIMP-1 was increased by Astragaloside Ⅳ at 20-100 ng/mL. In contrast, the mRNA levels of MMP-7, MMP-9, and TIMP-2 were not detectable in HT-29.
起訖頁 111-117
關鍵詞 一氧化氮急性神經退化神經毒性氧化壓力發炎粒線體功能異常天然物Nitric oxideAcute neurodegenerationNeurotoxicityOxidative stressInflammationMitochondrial dysfunctionNatural products
刊名 中醫藥雜誌  
期數 200506 (16:2-3期)
出版單位 衛生福利部國家中醫藥研究所(原:國立中國醫藥研究所)
該期刊-上一篇 電針對食源性肥胖大鼠血中瘦體素與胰島素的影響
該期刊-下一篇 臺灣產油相屬植物之組織學研究
 

新書閱讀



最新影音


優惠活動




讀者服務專線:+886-2-23756688 傳真:+886-2-23318496
地址:臺北市館前路28 號 7 樓 客服信箱
Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄